Zobrazeno 1 - 10
of 81
pro vyhledávání: '"La. Sutton"'
Autor:
Junyan Lu, Christoph Plass, Sascha Dietrich, Britta Velten, Ingo Ringshausen, Katja Zirlik, Emma Young, Marco Herling, Davide Rossi, C. von Kalle, Christopher C. Oakes, Simon Anders, Jan Dürig, Wolfgang Huber, Leopold Sellner, Thorsten Zenz, Małgorzata Oleś, A. Mock, Florence Nguyen-Khac, La. Sutton, Richard Rosenquist
Publikováno v:
Hematological Oncology. 35:56-56
Autor:
Kostas Stamatopoulos, Achilles Anagnostopoulos, Karin E. Smedby, Diego Cortese, Neus Villamor, Alba Navarro, C. Belessi, La. Sutton, E. Minga, Larry Mansouri, Gianluca Gaidano, Eugen Tausch, Paolo Ghia, Richard Rosenquist, Veronika Navrkalová, Šárka Pospíšilová, Jana Kminkova, Julio Delgado, Anastasia Hadzidimitriou, Lydia Scarfò, Gunnar Juliusson, Andreas Agathangelidis, Davide Rossi, Jonathan C. Strefford, Zadie Davis, Antonios M. Makris, Matthew J. J. Rose-Zerilli, David Oscier, Stephan Stilgenbauer, Panagiotis Baliakas, Elias Campo, Barbara Kantorová, Marta Larrayoz, Evangelia Stalika
Publikováno v:
Leukemia
Through the European Research Initiative on chronic lymphocytic leukemia (CLL) (ERIC), we screened 3490 patients with CLL for mutations within the NOTCH1 (n=3334), SF3B1 (n=2322), TP53 (n=2309), MYD88 (n=1080) and BIRC3 (n=919) genes, mainly at diagn
Autor:
Hägerstrand D; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Oder B; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Cortese D; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Qu Y; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Binzer-Panchal A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Österholm C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Del Peso Santos T; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Rabbani L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Asl HF; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Skaftason A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Ljungström V; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Lundholm A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Koutroumani M; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece., Haider Z; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Jylhä C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Clinical Genetics and Genomics, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden., Mollstedt J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Mansouri L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Plevova K; Department of Internal Medicine - Hematology and Oncology, Medical Faculty, Masaryk University and University Hospital Brno, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, Medical Faculty, Masaryk University and University Hospital Brno, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Agathangelidis A; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Department of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece., Scarfò L; Università Vita-Salute San Raffaele, Milan, Italy.; Division of Experimental Oncology, IRCCS, Ospedale San Raffaele, Milan, Italy., Armand M; Department of Hematology, Hospital Pitie-Salpetriere, Sorbonne University, Paris, France., Muggen AF; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Kay NE; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.; Department of Immunology, Mayo Clinic, Rochester, USA., Shanafelt T; Division of Hematology, Department of Medicine, Stanford University Medical Center, Stanford, CA, USA., Rossi D; Department of Hematology, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland., Orre LM; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden., Pospisilova S; Department of Internal Medicine - Hematology and Oncology, Medical Faculty, Masaryk University and University Hospital Brno, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, Medical Faculty, Masaryk University and University Hospital Brno, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Barylyuk K; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden., Davi F; Department of Hematology, Hospital Pitie-Salpetriere, Sorbonne University, Paris, France., Vesterlund M; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden., Langerak AW; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Lehtiö J; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden., Ghia P; Università Vita-Salute San Raffaele, Milan, Italy.; Division of Experimental Oncology, IRCCS, Ospedale San Raffaele, Milan, Italy., Stamatopoulos K; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. richard.rosenquist@ki.se.; Clinical Genetics and Genomics, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden. richard.rosenquist@ki.se.
Publikováno v:
Leukemia [Leukemia] 2024 Sep 11. Date of Electronic Publication: 2024 Sep 11.
Autor:
Apollonio B; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Spada F; BRC Advanced Cytometry Platform and., Petrov N; BRC Advanced Cytometry Platform and., Cozzetto D; BRC Translational Bioinformatics at Guy's and St. Thomas's NHS Foundation Trust and King's College London, London, United Kingdom.; Division of Digestive Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom., Papazoglou D; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Jarvis P; 5th Surgical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Kannambath S; BRC Genomics Research Platform at Guy's and St. Thomas's NHS Foundation Trust and King's College London, London, United Kingdom., Terranova-Barberio M; BRC Advanced Cytometry Platform and., Amini RM; Department of Immunology, Genetics and Pathology, Uppsala University and Hospital, Uppsala, Sweden., Enblad G; Department of Immunology, Genetics and Pathology, Uppsala University and Hospital, Uppsala, Sweden., Graham C; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Benjamin R; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Phillips E; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Ellis R; BRC Advanced Cytometry Platform and., Nuamah R; BRC Genomics Research Platform at Guy's and St. Thomas's NHS Foundation Trust and King's College London, London, United Kingdom., Saqi M; BRC Translational Bioinformatics at Guy's and St. Thomas's NHS Foundation Trust and King's College London, London, United Kingdom., Calado DP; Immunity & Cancer Laboratory, Francis Crick Institute, London, United Kingdom., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Salisbury J; Department of Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom., Zacharioudakis G; 5th Surgical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Vardi A; Hematology Department and HCT Unit, G. Papanikolaou Hospital, Thessaloniki, Greece., Hagner PR; Bristol-Myers Squibb, Summit, New Jersey, USA., Gandhi AK; Bristol-Myers Squibb, Summit, New Jersey, USA., Bacac M; Roche Innovation Center Zurich, Schlieren, Switzerland., Claus C; Roche Innovation Center Zurich, Schlieren, Switzerland., Umana P; Roche Innovation Center Zurich, Schlieren, Switzerland., Jarrett RF; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom., Klein C; Roche Innovation Center Zurich, Schlieren, Switzerland., Deutsch A; Division of Hematology, Medical University of Graz, Graz, Austria., Ramsay AG; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2023 Jul 03; Vol. 133 (13). Date of Electronic Publication: 2023 Jul 03.
Autor:
Bonfiglio S; Centre for Omics Sciences, IRCCS Ospedale San Raffaele, Milan, Italy.; Division of Experimental Oncology, B cell Neoplasia Unit, IRCCS Ospedale San Raffaele, Milan, Italy., Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Ljungström V; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden., Capasso A; Strategic Research Program on CLL, IRCCS Ospedale San Raffaele, Milan, Italy., Pandzic T; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden., Weström S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden., Foroughi-Asl H; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Skaftason A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Gellerbring A; Clinical Genomics Stockholm, Science for Life Laboratory, Solna, Sweden.; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Lyander A; Clinical Genomics Stockholm, Science for Life Laboratory, Solna, Sweden.; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, Sweden., Gandini F; Division of Experimental Oncology, B cell Neoplasia Unit, IRCCS Ospedale San Raffaele, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Trentin L; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Italy., Bonello L; Molecular Pathology Unit, A.O.U Città della Salute e della Scienza, Torino, Italy.; Department of Molecular Biotechnologies and Health Sciences, Università di Torino, Italy., Reda G; Department of Hematology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Bödör C; HCEMM-SU Molecular Oncohematology Research Group, Budapest, Hungary.; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Stavroyianni N; Department of Hematology and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Tam CS; Department of Hematology, Alfred Health, Melbourne, Victoria, Australia.; Central Clinical School, Monash University, Melbourne, Victoria, Australia., Marasca R; Department of Medical and Surgical Sciences, Hematology Unit, University of Modena and Reggio Emilia, Modena, Italy., Forconi F; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Department of Hematology, University Hospital National Health Service Trust, Southampton, United Kingdom., Panayiotidis P; Department of Propaedeutic Internal Medicine, Laiko Hospital, University of Athens, Athens, Greece., Ringshausen I; Department of Hematology, University of Cambridge, Cambridge, United Kingdom., Jaksic O; Dubrava University Hospital, Zagreb, Croatia., Frustaci AM; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Iyengar S; Department of Haemato-Oncology, Royal Marsden Hospital, London, United Kingdom., Coscia M; Department of Molecular Biotechnologies and Health Sciences, Università di Torino, Italy.; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy., Mulligan SP; Department of Haematology, Royal North Shore Hospital, University of Sydney, Sydney, Australia., Ysebaert L; Département d'Hématologie, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France., Strugov V; Almazov National Medical Research Centre, St Petersburg, Russia., Pavlovsky C; FUNDALEU, Clinical Research Center, Buenos Aires, Argentina., Walewska R; Department of Molecular Pathology, University Hospitals Dorset, Bournemouth, United Kingdom., Österborg A; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Cortese D; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Ranghetti P; Division of Experimental Oncology, B cell Neoplasia Unit, IRCCS Ospedale San Raffaele, Milan, Italy., Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden., Stamatopoulos K; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece., Scarfò L; Division of Experimental Oncology, B cell Neoplasia Unit, IRCCS Ospedale San Raffaele, Milan, Italy.; Strategic Research Program on CLL, IRCCS Ospedale San Raffaele, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden., Ghia P; Division of Experimental Oncology, B cell Neoplasia Unit, IRCCS Ospedale San Raffaele, Milan, Italy.; Strategic Research Program on CLL, IRCCS Ospedale San Raffaele, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy.
Publikováno v:
Blood advances [Blood Adv] 2023 Jun 27; Vol. 7 (12), pp. 2794-2806.
Autor:
Chen DY; Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri 63110, USA; davidchen@wustl.edu., Sutton LA; Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri 63110, USA., Ramakrishnan SM; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110, USA., Duncavage EJ; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, USA., Heath SE; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110, USA., Compton LA; Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, USA., Miller CA; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110, USA., Ley TJ; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Publikováno v:
Cold Spring Harbor molecular case studies [Cold Spring Harb Mol Case Stud] 2023 May 09; Vol. 9 (2). Date of Electronic Publication: 2023 May 09 (Print Publication: 2023).
Autor:
Mansouri L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Thorvaldsdottir B; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Karakatsoulis G; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece.; Department of Mathematics, University of Ioannina, Ioannina, Greece., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Parker H; Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Brieghel C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Laidou S; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece., Moia R; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Rossi D; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Catherwood M; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Kotaskova J; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Delgado J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Rodríguez-Vicente AE; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Benito R; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rigolin GM; Hematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Bonfiglio S; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Scarfo L; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Mattsson M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Davis Z; Molecular Pathology Department, University Hospitals Dorset, Bournemouth, UK., Gogia A; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Rani L; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Baliakas P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Foroughi-Asl H; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Jylhä C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Skaftason A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Rapado I; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., Miras F; Hospital Universitario 12 Octubre, Madrid, Spain., Martinez-Lopez J; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., de la Serna J; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., Rivas JMH; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Thornton P; Haematology Department, Beaumont Hospital, Dublin, Ireland., Larráyoz MJ; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Calasanz MJ; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Fésüs V; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Mátrai Z; Central Hospital of Southern Pest-National Institute of Hematology and Infectious Diseases, Budapest, Hungary., Bödör C; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Smedby KE; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Espinet B; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain., Puiggros A; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain., Gupta R; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Bullinger L; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Bosch F; Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Tazón-Vega B; Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Baran-Marszak F; Service d'hématologie Biologique Hôpital Avicenne Assistance Publique des Hôpitaux de Paris, Bobigny, France., Oscier D; Molecular Pathology Department, University Hospitals Dorset, Bournemouth, UK., Nguyen-Khac F; Sorbonne Université, Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Zenz T; Department of Oncology and Haematology, University Hospital and University of Zurich, Zurich, Switzerland., Terol MJ; Department of Hematology, INCLIVA Research Insitute, University of Valencia, Valencia, Spain., Cuneo A; Hematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Hernández-Sánchez M; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Pospisilova S; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Mills K; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Strefford JC; Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Ghia P; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Stamatopoulos K; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. richard.rosenquist@ki.se.; Clinical Genetics, Karolinska University Hospital, Solna, Sweden. richard.rosenquist@ki.se.
Publikováno v:
Leukemia [Leukemia] 2023 Feb; Vol. 37 (2), pp. 504.
Autor:
Shea LK; Division of Oncology, John T. Milliken Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Akhave NS; Division of Oncology, John T. Milliken Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Sutton LA; Division of Dermatology, John T. Milliken Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Compton LA; Division of Dermatology, John T. Milliken Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA; Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., York C; Division of Oncology, John T. Milliken Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Ramakrishnan SM; Division of Oncology, John T. Milliken Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Miller CA; Division of Oncology, John T. Milliken Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Wartman LD; Division of Oncology, John T. Milliken Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Chen DY; Division of Dermatology, John T. Milliken Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA. Electronic address: davidchen@wustl.edu.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2023 Feb; Vol. 143 (2), pp. 232-241.e6. Date of Electronic Publication: 2022 Aug 31.
Autor:
Mansouri L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Thorvaldsdottir B; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Karakatsoulis G; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece.; Department of Mathematics, University of Ioannina, Ioannina, Greece., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Parker H; Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Brieghel C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Laidou S; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece., Moia R; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Rossi D; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Catherwood M; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Kotaskova J; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Delgado J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Rodríguez-Vicente AE; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Benito R; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rigolin GM; Hematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Bonfiglio S; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Scarfo L; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Mattsson M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Davis Z; Molecular Pathology Department, University Hospitals Dorset, Bournemouth, UK., Gogia A; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Rani L; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Baliakas P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Foroughi-Asl H; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Jylhä C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Skaftason A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Rapado I; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., Miras F; Hospital Universitario 12 Octubre, Madrid, Spain., Martinez-Lopez J; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., de la Serna J; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., Rivas JMH; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Thornton P; Haematology Department, Beaumont Hospital, Dublin, Ireland., Larráyoz MJ; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Calasanz MJ; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Fésüs V; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Mátrai Z; Central Hospital of Southern Pest-National Institute of Hematology and Infectious Diseases, Budapest, Hungary., Bödör C; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Smedby KE; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Espinet B; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain., Puiggros A; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain., Gupta R; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Bullinger L; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Bosch F; Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Tazón-Vega B; Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Baran-Marszak F; Service d'hématologie Biologique Hôpital Avicenne Assistance Publique des Hôpitaux de Paris, Bobigny, France., Oscier D; Molecular Pathology Department, University Hospitals Dorset, Bournemouth, UK., Nguyen-Khac F; Sorbonne Université, Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Zenz T; Department of Oncology and Haematology, University Hospital and University of Zurich, Zurich, Switzerland., Terol MJ; Department of Hematology, INCLIVA Research Insitute, University of Valencia, Valencia, Spain., Cuneo A; Hematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Hernández-Sánchez M; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Pospisilova S; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Mills K; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Strefford JC; Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Ghia P; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Stamatopoulos K; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. richard.rosenquist@ki.se.; Clinical Genetics, Karolinska University Hospital, Solna, Sweden. richard.rosenquist@ki.se.
Publikováno v:
Leukemia [Leukemia] 2023 Feb; Vol. 37 (2), pp. 339-347. Date of Electronic Publication: 2022 Dec 24.
Autor:
Chiodin G; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Drennan S; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; T-Cypher Bio, Oxford, United Kingdom., Martino EA; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Department of Haematology, Azienda Ospedaliera di Cosenza, Cosenza, Italy., Ondrisova L; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Molecular Medicine, CEITEC Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Henderson I; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Del Rio L; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Tracy I; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., D'Avola A; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; The Francis Crick Institute, London, United Kingdom., Parker H; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Bonfiglio S; Strategic Research Program on CLL and B-cell Neoplasia Unit, Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy., Scarfò L; Strategic Research Program on CLL and B-cell Neoplasia Unit, Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy., Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; and., Strefford JC; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Forster J; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Brake O; Haematology Department, Cancer Care Directorate, University Hospital Southampton NHS Trust, Southampton, United Kingdom., Potter KN; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Sale B; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Lanham S; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Mraz M; Molecular Medicine, CEITEC Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Ghia P; Strategic Research Program on CLL and B-cell Neoplasia Unit, Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy., Stevenson FK; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Forconi F; School of Cancer Sciences, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Haematology Department, Cancer Care Directorate, University Hospital Southampton NHS Trust, Southampton, United Kingdom.
Publikováno v:
Blood advances [Blood Adv] 2022 Sep 27; Vol. 6 (18), pp. 5494-5504.